SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 193 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $266,000 | -14.7% | 1,900 | -7.5% | 0.01% | +40.0% |
| Q2 2019 | $312,000 | -98.7% | 2,054 | -98.8% | 0.01% | -98.8% |
| Q2 2018 | $23,455,000 | +4350.7% | 177,445 | +897.5% | 0.43% | +7050.0% |
| Q1 2017 | $527,000 | -4.2% | 17,789 | -11.4% | 0.01% | +20.0% |
| Q4 2016 | $550,000 | +34.1% | 20,067 | +57.5% | 0.01% | -44.4% |
| Q3 2015 | $410,000 | -69.4% | 12,741 | -71.7% | 0.01% | -83.6% |
| Q2 2014 | $1,341,000 | -44.2% | 45,000 | -55.0% | 0.06% | -64.5% |
| Q1 2014 | $2,403,000 | +56.0% | 100,000 | +32.3% | 0.16% | +101.3% |
| Q4 2013 | $1,540,000 | +27.4% | 75,572 | +195.2% | 0.08% | +60.4% |
| Q3 2013 | $1,209,000 | – | 25,599 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |